Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)
6617.TWO Stock Price Chart
Explore Gongwin Biopharm Holdings Co., Ltd. interactive price chart. Choose custom timeframes to analyze 6617.TWO price movements and trends.
6617.TWO Company Profile
Discover essential business fundamentals and corporate details for Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) to support your stock research and investment decisions.
Sector
Industrials
Industry
Medical - Distribution
IPO Date
8 Feb 2017
Employees
—
Website
https://www.gongwinbiopharm.comCEO
Chonghan Wu
Description
Gongwin Biopharm Holdings Co., Ltd., a clinical-stage biopharmaceutical company, develops anticancer drugs. It is developing PTS302, which has completed Phase III clinical trials for the treatment of lung cancer; PTS100, which is in Phase II clinical trials for the treatment of liver cancer; PTS-02 for the treatment of adenoid cystic carcinoma; and PTS500 for the treatment of malignant pleural effusion. The company was founded in 2014 and is based in Taipei, Taiwan.
6617.TWO Financial Timeline
Browse a chronological timeline of Gongwin Biopharm Holdings Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 20 Jul 2022
Shares were split 253 : 250 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 17 Sept 2020
Shares were split 128 : 125 , changing the number of shares outstanding and the price per share accordingly.
6617.TWO Stock Performance
Access detailed 6617.TWO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.